| Autor: |
Pollack AS; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA., Kunder CA; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA., Brazer N; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA., Shen Z; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA., Varma S; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA., West RB; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA., Cunha GR; Department of Urology, University of California, San Francisco (UCSF), San Francisco, California, USA., Baskin LS; Department of Urology, University of California, San Francisco (UCSF), San Francisco, California, USA., Brooks JD; Department of Urology, Stanford University School of Medicine, Stanford, California, USA., Pollack JR; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA. |
| Abstrakt: |
Benign prostatic hyperplasia (BPH) is the nodular proliferation of the prostate transition zone in older men, leading to urinary storage and voiding problems that can be recalcitrant to therapy. Decades ago, John McNeal proposed that BPH originates with the "reawakening" of embryonic inductive activity by adult prostate stroma, which spurs new ductal proliferation and branching morphogenesis. Here, by laser microdissection and transcriptional profiling of the BPH stroma adjacent to hyperplastic branching ducts, we identified secreted factors likely mediating stromal induction of prostate glandular epithelium and coinciding processes. The top stromal factors were insulin-like growth factor 1 (IGF1) and CXC chemokine ligand 13 (CXCL13), which we verified by RNA in situ hybridization to be coexpressed in BPH fibroblasts, along with their cognate receptors (IGF1R and CXCR5) on adjacent epithelium. In contrast, IGF1 but not CXCL13 was expressed in human embryonic prostate stroma. Finally, we demonstrated that IGF1 is necessary for the generation of BPH-1 cell spheroids and patient-derived BPH cell organoids in 3D culture. Our findings partially support historic speculations on the etiology of BPH and provide what we believe to be new molecular targets for rational therapies directed against the underlying processes driving BPH. |
